Abbott India Faces Consecutive Losses Amid Broader Sector Downturn

Abbott India Ltd., a prominent player in the Pharmaceuticals & Biotechnology sector, has experienced a notable decline of 3.48% on August 1, 2025. This drop comes as the stock has underperformed its sector by 0.56%, marking its second consecutive day of losses, with a total decline of 5.35% over this period. The stock reached an intraday low of Rs 33,183.75, reflecting a decrease of 3.82%.
In terms of moving averages, Abbott India’s stock is currently above the 50-day, 100-day, and 200-day moving averages, yet it remains below the 5-day and 20-day moving averages. The broader Pharmaceuticals & Drugs sector has also seen a downturn, falling by 3.09%.

On the market front, the Sensex has continued its downward trend, opening lower and dropping by 528.53 points to settle at 80,545.88, a decline of 0.79%. Abbott India’s performance over various time frames shows a year-to-date increase of 12.22% and a significant 647.16% rise over the past decade, outperforming the Sensex in both short and long-term metrics.